enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Infant respiratory distress syndrome - Wikipedia

    en.wikipedia.org/wiki/Infant_respiratory...

    Infant respiratory distress syndrome (IRDS), also known as surfactant deficiency disorder (SDD), [2] and previously called hyaline membrane disease (HMD), is a syndrome in premature infants caused by developmental insufficiency of pulmonary surfactant production and structural immaturity in the lungs.

  3. Surfactant therapy - Wikipedia

    en.wikipedia.org/wiki/Surfactant_therapy

    Conditions adult respiratory distress syndrome or Hyaline Membrane Disease are also sometimes treated with exogenously derived surfactant. One of the more common uses of surfactant therapy is to treat alveolar surfactant deficiency in premature newborns. Most commonly, treatment is composed of multiple doses of 100 mg/kg of exogenous surfactant ...

  4. Maroteaux–Lamy syndrome - Wikipedia

    en.wikipedia.org/wiki/Maroteaux–Lamy_syndrome

    At birth, people with Maroteaux–Lamy syndrome typically do not display any signs or symptoms. [4] Signs are revealed early in the affected child's life, with one of the first symptoms often being a significantly prolonged age of learning how to walk. Growth begins normally, but children usually stop growing by age 8.

  5. Pulmonary surfactant (medication) - Wikipedia

    en.wikipedia.org/wiki/Pulmonary_surfactant...

    Pulmonary surfactant is used as a medication to treat and prevent respiratory distress syndrome in newborn babies. [1] Prevention is generally done in babies born at a gestational age of less than 32 weeks. [1] It is given by the endotracheal tube. [1] Onset of effects is rapid. [2] A number of doses may be needed. [2]

  6. Surfactant metabolism dysfunction - Wikipedia

    en.wikipedia.org/wiki/Surfactant_metabolism...

    Neonates with surfactant metabolism dysfunctions, especially those with SP-B disorder, only have lung transplantation as one possible choice of treatment. [3] Children with lung transplant due to surfactant metabolism dysfunction perform on similar level to those with transplant for due to other reasons. [ 3 ]

  7. Transient tachypnea of the newborn - Wikipedia

    en.wikipedia.org/wiki/Transient_tachypnea_of_the...

    Pleural effusions can also develop, which are also seen with meconium aspiration but not with respiratory distress syndrome. [2] The lungs may also appear hyperinflated. [5] It is a diagnosis of exclusion as it is a benign condition that can have symptoms and signs similar to more serious syndromes, such as respiratory distress or meconium ...

  8. Annuity vs 401(k): Which Vehicle Is Actually Better for Your ...

    www.aol.com/annuity-vs-401-k-vehicle-202514980.html

    Anyone choosing a 401(k) must do so knowing the volatility risks of the market. Going with an annuity means guaranteed income after retirement. Both annuities and 401(k) accounts have pros and cons.

  9. John Allen Clements - Wikipedia

    en.wikipedia.org/wiki/John_Allen_Clements

    John Allen Clements (March 16, 1923 – September 3, 2024) was an American physician and physiologist known for his role in the discovery of pulmonary surfactant, a crucial factor in the development of life-saving treatments for neonatal respiratory distress syndrome. His research revolutionized the care of premature infants, greatly reducing ...

  1. Related searches when do babies develop surfactant deficiency treatment mayo clinic pictures

    surfactant therapy wikipediawhat is pulmonary surfactant
    exogenous surfactant therapy